Skip to main content
. 2011 May 12;2(4):579–584. doi: 10.3892/etm.2011.272

Table I.

Clinical characteristics of the patients.

Pt. no. Age (years) Time of castration (months) CAB AA withdrawal Previous treatment Pain (1–3) Other symptoms Bone metastasis Other sites of metastasis
1 50 45 Yes Yes Atrasentan 1 Difficulty urinating Yes Lymph node
2 75 7 Yes Yes None 1 Yes Liver
3 40 6 Yes No None 3 Partial ileus, recurrent infection, fracture Yes Lymph node, liver, bladder
4 74 68 Yes Yes Prednisone 1 Yes 0
5 62 108 Yes Yes Prednisone 1 Yes 0
6 46 46 Yes Yes None 1 Yes 0
7 63 62 Yes Yes Predisone, bisphosphonates, Sendoxan 2 No Lymph node
8 65 84 Yes Yes None 1 Edema NC 0
9 62 36 Yes Yes None 1 Yes 0
10 58 56 Yes Yes None 1 Yes 0
11 59 104 Yes No Prednisone 1 Spinal cord, compression, weakness in arms and legs Yes 0
12 70 106 Yes No None 1 Incontinence after TUR-P, lymphostasis Yes Lymph node
13 57 14 Yes No None 1 Urine retention, supra-pubic catheter Yes Lymph node
14 63 35 Yes Yes Prednisone 1 NC Lymph node
15 62 79 Yes Yes None 1 Yes Lymph node
16 55 15 Yes No None 2 Lymphostasis Yes Lymph node
17 59 17 Yes Yes None 1 Yes Lymph node

TUR-P, transurethral resection of the prostate; NC, not confirmed; CAB, combined androgen blockade; AA, anti-androgen.